(Q40753379)

English

The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group

scientific article published on August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

chronic renal disease

1 reference

based on heuristic

inferred from title

author name string

Bakris GL

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Whelton P

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Weir M

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Mimran A

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Keane W

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Schiffrin E

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

815-825

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

End-stage renal disease attributable to diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Pathogenesis and course of renal disease in IDDM/NIDDM: differences and similarities

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Understanding the nature of renal disease progression

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study.

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Renal protective effect of enalapril in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009549

21 January 2018

Identifiers

10.1177/00912700022009549

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40753379&oldid=1906696204"